Physician profile
Shoji Ishigami
NPI 1699065771
$3,075.02
in general payments reported to CMS, 2019-2025
9 companies · $359 in 2025
The $359 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,256 · 2021: $23.00 · 2022: $160 · 2023: $83.42 · 2024: $1,194 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $890 · Food and Beverage: $746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $889.94 |
| Food and Beverage | $746.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,450.49 | 2019-2025 | Intracept, General - Pain Management |
| Medtronic, INC. | $1,267.11 | 2024-2025 | Intellis Adaptivestim, Fusion, Inceptiv |
| Relievant Medsystems, INC. | $133.48 | 2022-2023 | Intracept |
| Spr Therapeutics, INC | $79.01 | 2022-2024 | Sprint Pns System |
| Abbvie INC. | $40.03 | 2024-2025 | |
| Medtronic USA, INC. | $29.50 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $27.03 | 2025 | Iovera |
| Averitas Pharma INC. | $25.37 | 2025 | Qutenza |
| Avanos Medical | $23.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shoji Ishigami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.